What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Bacteria
Her primary areas of investigation include Innate immune system, NOD1, Cell biology, Microbiology and NOD2.
Her biological study spans a wide range of topics, including Proinflammatory cytokine and Host Defense Mechanism.
Dana J. Philpott has researched NOD1 in several fields, including Pathogen, Nod1 Signaling Adaptor Protein and Nod Signaling Adaptor Proteins.
The various areas that Dana J. Philpott examines in her Cell biology study include Autophagy, Receptor, Shigella flexneri and NLRX1.
Her Microbiology research incorporates elements of Plasmid, Immunity, Staphylococcus aureus, Peptidoglycan and Immunoelectron microscopy.
Her NOD2 research incorporates themes from Muramyl dipeptide and Signal transduction.
Her most cited work include:
- Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. (1935 citations)
- Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan (1300 citations)
- Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island (1029 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Cell biology, Innate immune system, NOD1 and Microbiology.
Dana J. Philpott interconnects Autophagy and Receptor in the investigation of issues within Cell biology.
The study incorporates disciplines such as Chemokine and TLR4 in addition to Innate immune system.
Her NOD1 research focuses on subjects like Peptidoglycan, which are linked to Pathogen.
Her work carried out in the field of Microbiology brings together such families of science as Helicobacter, Helicobacter pylori, Secretion, TLR2 and Immunity.
Her NOD2 study combines topics in areas such as Proinflammatory cytokine, Muramyl dipeptide, Signal transduction and Cytokine.
She most often published in these fields:
- Immunology (38.19%)
- Cell biology (36.22%)
- Innate immune system (33.07%)
What were the highlights of her more recent work (between 2015-2021)?
- Immunology (38.19%)
- Cell biology (36.22%)
- Innate immune system (33.07%)
In recent papers she was focusing on the following fields of study:
Dana J. Philpott mainly investigates Immunology, Cell biology, Innate immune system, Autophagy and Immune system.
She has included themes like Inflammatory bowel disease and Microbiology in her Immunology study.
Dana J. Philpott combines subjects such as Intracellular and Immunity with her study of Microbiology.
Her Cell biology study integrates concerns from other disciplines, such as Inflammasome and Intestinal mucosa.
Her Innate immune system study incorporates themes from Helicobacter and Nod.
Her NOD2 study focuses on NOD1 in particular.
Between 2015 and 2021, her most popular works were:
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models. (59 citations)
- Shiga Toxin/Lipopolysaccharide Activates Caspase-4 and Gasdermin D to Trigger Mitochondrial Reactive Oxygen Species Upstream of the NLRP3 Inflammasome. (50 citations)
- The NLR Protein NLRP6 Does Not Impact Gut Microbiota Composition (49 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Bacteria
Dana J. Philpott mostly deals with Immunology, Innate immune system, Inflammation, Gut flora and Microbiology.
Her research investigates the connection with Immunology and areas like Inflammatory bowel disease which intersect with concerns in Genetic predisposition, Weaning, Antibiotics and Amoxicillin.
Her research on Innate immune system focuses in particular on NOD1.
Her NOD1 research integrates issues from Endoplasmic reticulum, Signal transduction, TRIF and ATF4.
Her studies deal with areas such as Receptor, Internal medicine and Endocrinology as well as Gut flora.
Her Microbiology research focuses on Intracellular and how it connects with Autophagy and Adjuvant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
